These groundbreaking therapies have offered millions a renewed sense of health and well-being
[1] In phase 3 trials, orforglipron produced 12.4% weight loss (27.3 lbs) at 72 weeks less than injectable tirzepatide (20%) but comparable to oral semaglutide
Youll be paired with a clinician who can assess whether weight loss medication is right for you and prescribe it if needed
Klarity handles: Patient acquisition and matching (qualified patients already seeking psychiatric or weight management care) Telehealth infrastructure (HIPAA-compliant video, EHR integration) Credentialing across multiple insurance plans Both insurance and cash-pay patient flow You control your schedule and only pay when a patient books with you
For UK availability, visit the Retatrutide UK page
While you may see lots of dramatic weight loss stories on social media, studies have shown that among adults who were overweight or obese, those who injected semaglutide lost nearly 15% of their body weight after 68 weeks